SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950142-23-001652
Filing Date
2023-06-09
Accepted
2023-06-09 15:05:53
Documents
1
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es230368218_4-finch.html 4  
1 OWNERSHIP DOCUMENT es230368218_4-finch.xml 4 3971
  Complete submission text file 0000950142-23-001652.txt   5439
Mailing Address 28 HAVEMEYER PLACE GREENWICH CT 06830
Business Address
Shumway Chris (Reporting) CIK: 0001222119 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40227 | Film No.: 231004950

Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 617-229-6499
Finch Therapeutics Group, Inc. (Issuer) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)